Related references
Note: Only part of the references are listed.Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
Michelle M. McDonald et al.
CELL (2021)
Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations
Nadja Fratzl-Zelman et al.
BONE (2021)
Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23
Riikka E. Makitie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
Yugang Wang et al.
TRANSLATIONAL ONCOLOGY (2020)
Mesenchymal Cell-Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation
Fan Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung
Jiankang Zhang et al.
CLINICAL CANCER RESEARCH (2019)
Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists
Gill Holdsworth et al.
BONE (2018)
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
Noopur Raje et al.
LANCET ONCOLOGY (2018)
Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition
Phillip C. Witcher et al.
JCI INSIGHT (2018)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma
Michelle M. McDonald et al.
BLOOD (2017)
Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways
Megan M. Weivoda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats
Scott Taylor et al.
BONE (2016)
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Monica Florio et al.
NATURE COMMUNICATIONS (2016)
CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells
Paula Ruiz et al.
SCIENTIFIC REPORTS (2016)
Bone metastasis: the importance of the neighbourhood
Peter I. Croucher et al.
NATURE REVIEWS CANCER (2016)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
Reversing LRP5-Dependent Osteoporosis and SOST Deficiency-Induced Sclerosing Bone Disorders by Altering WNT Signaling Activity
Ming-Kang Chang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling
Changjun Li et al.
BONE RESEARCH (2014)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition
Ryan C. Riddle et al.
PLOS ONE (2013)
A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice
Kevin A. Maupin et al.
BONE RESEARCH (2013)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
Wei Wei et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Pathogenesis of Myeloma Bone Disease
G. David Roodman
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies
Yan Gong et al.
PLOS ONE (2010)
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
Seth A. Ettenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
Deborah J. Heath et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF
Ken-ichi Fujita et al.
MOLECULAR CANCER (2007)
Production of Wnt inhibitors by myeloma cells: Potential effects on canonical Wnt pathway in the bone microenvironment
Nicola Giuliani et al.
CANCER RESEARCH (2007)
Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging
Babatunde O. Oyajobi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby et al.
BLOOD (2007)
Multiple myeloma bone disease: pathophysiology of osteoblast inhibition
Nicola Giuliani et al.
BLOOD (2006)
Wnt signaling and osteoblastogenesis
Peter V. N. Bodine et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2006)
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma
William G. Gunn et al.
STEM CELLS (2006)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
PWB Derksen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Share Paper
